- 全部删除
- 您的购物车当前为空
Naldemedine (S 297995) is a peripheral selective μ-opioid receptor antagonist being developed by Shionogi for the treatment of opioid-induced adverse reactions, including constipation, nausea, and vomiting. They are usually well tolerated, mainly with mild to moderate gastrointestinal side effects.
Naldemedine (S 297995) is a peripheral selective μ-opioid receptor antagonist being developed by Shionogi for the treatment of opioid-induced adverse reactions, including constipation, nausea, and vomiting. They are usually well tolerated, mainly with mild to moderate gastrointestinal side effects.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
25 mg | 询价 | 10-14周 | |
50 mg | 询价 | 10-14周 | |
100 mg | 询价 | 10-14周 |
产品描述 | Naldemedine (S 297995) is a peripheral selective μ-opioid receptor antagonist being developed by Shionogi for the treatment of opioid-induced adverse reactions, including constipation, nausea, and vomiting. They are usually well tolerated, mainly with mild to moderate gastrointestinal side effects. |
别名 | S-297995, S297995, S297,995;Naldemedine, S-297,995, S297,995, S 297995, S 297,995, Naldemedine |
分子量 | 570.64 |
分子式 | C32H34N4O6 |
CAS No. | 916072-89-4 |
密度 | 1.31g/cm3 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容